Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment

Full text for this resource is not available from the Research Repository.

Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Qaradakhi, Tawar, McSweeney, K ORCID: 0000-0003-4146-8251, Ashiana Ali, B, Zulli, Anthony ORCID: 0000-0002-2660-078X and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2021) Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment. Future Microbiology, 16 (4). pp. 205-209. ISSN 1746-0913

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/43114
DOI https://doi.org/10.2217/fmb-2021-0018
Official URL https://www.futuremedicine.com/doi/10.2217/fmb-202...
Subjects Current > FOR (2020) Classification > 3208 Medical physiology
Current > Division/Research > College of Health and Biomedicine
Keywords Corona virus, Covid 19, SARS-CoV-1 pandemic response, treatment, Covid 19 treatment
Citations in Scopus 6 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login